APA (7th ed.) Citation

Jacob P. Thyssen, Thomas Bieber, C. Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, . . . Andreas Wollenberg. (2023). Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jacob P. Thyssen, Thomas Bieber, C. Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, Elisabeth Riedl, and Andreas Wollenberg. Baricitinib Provides Rapid and Sustained Improvements in Absolute EASI and SCORAD Outcomes in Adults with Moderate-to-severe Atopic Dermatitis. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Jacob P. Thyssen, et al. Baricitinib Provides Rapid and Sustained Improvements in Absolute EASI and SCORAD Outcomes in Adults with Moderate-to-severe Atopic Dermatitis. Taylor & Francis Group, 2023.